Neurodegenerative Market Forecast to 2013 (TA222)

Neurodegenerative Market Forecast to 2013 (TA222)
Profiled Brands in Alzheimer's, Multiple Sclerosis and Parkinson’s
 

Alzheimer's Disease

  • Anti-Amyloid Beta (Plaques)
    • Bapineuzumab / AAB-001
    • LY450139
    • LY2062430
    • ACC-001
  • Acetylcholinesterase Inhibitors
    • Aricept
    • Excelon
    • Razadyne
  • NMDA Antagonists
    • Namenda: also known as Ebixa in some EU countries
    • Ebixa: also known as Namenda in US
  • Other Alzheimer’s Therapies Targeting Neurotransmitters
    • Abilify
    • Dimebon
    • AZD3480 / TC-1734
    • SB 742457
  • Other Alzheimer’s Therapies
    • MEM1003
    • Tanakan
    • Avandia XR


Multiple Sclerosis (MS)

  • Immunomodulators
    • Copaxone
    • Fingolimod (FTY720)
    • BG-12 (Phase III)
    • Laquinimod (Phase III)
    • Teriflunomide
    • Oral Leustatin
  • Interferon Beta
    • Avonex
    • Rebif
    • Betaseron / Betaferon
  • Monoclonal antibodies
    • Rituxan
    • HuMax CD
    • Campath
    • Tysabri
    • SB689699
  • Other MS Therapies
    • Dirucotide (MBP8298)
    • Fampridine SR


Parkinson’s

  • Dopamineric drugs
    • Apokyn
    • Mirapex
    • Sinemet
    • Requip XL
    • Comtan / Stavelo
  • Other Drugs
    • Agilect / Azilect
    • ACP-103
    • Droxidopa